Always follow your healthcare providers recommended dosing schedule, and never adjust your dose without guidance
When evaluating retatrutide research data, the safety profile appears manageable and consistent with the GLP-1/GIP/glucagon receptor agonist class
Adverse Reactions / Side Effects Nausea Diarrhea Decreased appetite Vomiting Constipation Dyspepsia (indigestion) Abdominal pain If side effects are severe or persistent, contact your healthcare provider
The triple agonist mechanism activates three separate receptor pathways creating synergistic metabolic effects that single or dual agonists cannot replicate
[1] [8] These gastrointestinal effects are generally dose-dependent and can be minimized through gradual dose escalation
Aronne, world-renowned physician, researcher, professor and leading expert in weight management and GLP-1 medications